Motor abnormalities: From neurodevelopmental to neurodegenerative through "functional" (Neuro) psychiatric disorders

Schizophrenia Bulletin

Volumn 43, Issue 5, 2017, Pages 956-971

  Peralta, Victor ^a,b   Cuesta, Manuel J ^b,c  

^a Instituto de Investigación Sanitaria de Navarra   (Spain)

^b IdiSNA Navarra Institute for Health Research   (Spain)

^c Instituto de Investigación Sanitaria de Navarra   (Spain)

Author keywords

Alzheimer's disease; autism spectrum disorders; mood disorders; obsessive compulsive disorder; psychosis; schizophrenia

Indexed keywords

ALZHEIMER DISEASE; ARTICLE; AUTISM; CATATONIA; DEGENERATIVE DISEASE; EXTRAPYRAMIDAL SYMPTOM; HUMAN; MENTAL DISEASE; MOOD DISORDER; OBSESSIVE COMPULSIVE DISORDER; PHENOMENOLOGY; PREVALENCE; PRIORITY JOURNAL; PSYCHOSIS; SCHIZOPHRENIA; COMPLICATION; MOTOR DYSFUNCTION;

ALZHEIMER DISEASE; AUTISM SPECTRUM DISORDER; HUMANS; MOOD DISORDERS; MOVEMENT DISORDERS; OBSESSIVE-COMPULSIVE DISORDER; PSYCHOTIC DISORDERS; SCHIZOPHRENIA;

EID: 85032031520     PISSN: 05867614     EISSN: 17451701     Source Type: Journal    
DOI: 10.1093/schbul/sbx089     Document Type: Article

References (277)

1. Borsboom D. A network theory of mental disorders. World Psychiatry. 2017;16:5-13.
2. Kotov R, Watson D, Bagby RM, et al. The hierarchical taxonomy of psychopathology (HiTOP): Adimensional alternative to traditional nosologies. J Abnorm Psychol. 2017; 126:454-477.
3. Wigman JT, de Vos S, Wichers M, van Os J, Bartels-Velthuis AA. A transdiagnostic network approach to psychosis. Schizophr Bull. 2017;43:122-132.
4. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 5th ed. Washington, DC: American Psychiatric Association; 2013.
5. Leonhard K. The classification of endogenous psychoses. Translated by R Berman (1979). New York, NY: Irvington Publishers Inc; 1957.
6. McNeil TF, Cantor-Graae E. Neuromotor markers of risk for schizophrenia. Aust N Z J Psychiatry. 2000;34:65-73.
7. Wolff AL, O'Driscoll GA. Motor deficits and schizophrenia: The evidence from neuroleptic-naïve patients and populations at risk. J Psychiatry Neurosci. 1999;24:304-314.
8. Peralta V, Cuesta MJ, Serrano JF, Martinez-Larrea JA. Classification issues in catatonia. Eur Arch Psychiatry Clin Neurosci. 2001;251(suppl 1):14-66.
9. Pfuhlmann B, Stöber G. The different conceptions of catatonia: Historical overview and critical discussion. Eur Arch Psychiatry Clin Neurosci. 2001;251(suppl 1):4-7.
10. Steck H. Les syndromes extrapiramidaus dans les maladies mentales. Arch Suiss Neurol Psychiatr. 1926;19:195-233.
11. Kleist K. Die Katatonien. Nervenarzt. 1943;16:1-10.
12. Torrey EF. Studies of individuals with schizophrenia never treated with antipsychotic medications: A review. Schizophr Res. 2002;58:101-115.
13. Blumer D. Catatonia and the neuroleptics: Psychobiologic significance of remote and recent findings. Compr Psychiatry. 1997;38:193-201.
14. Ungvary GS, Kau LS, Wai-Kwong T, Shing NF. The pharmacological treatment of catatonia: An overview. Eur Arch Psychiatry Clin Neurosci. 2001;251 (suppl 1):31-34.
15. Fink M, Taylor MA. Catatonia. A clinicians Guide to Diagnosis and Treatment. Cambridge, UK: Cambridge University Press; 2003.
16. Lohr JB, Wisniewski AA. Movement disorders. A neuropsychiatric approach. New York, NY: The Guilford Press; 1987.
17. Ungvari GS, Caroff SN, Gerevich J. The catatonia conundrum: Evidence of psychomotor phenomena as a symptom dimension in psychotic disorders. Schizophr Bull. 2010;36:231-238.
18. Peralta V, Campos MS, De Jalón EG, Cuesta MJ. Motor behavior abnormalities in drug-naïve patients with schizophrenia spectrum disorders. Mov Disord. 2010;25:1068-1076.
19. Bernard JA, Mittal VA. Updating the research domain criteria: The utility of a motor dimension. Psychol Med. 2015;45:2685-2689.
20. Carroff SN, Mann SC, Francis A, Fricchione GL. Catatonia, from Psychopathology to Neurobiology. Washington, DC: American Psychiatric Publishing, Inc; 2004.
21. Northoff G. Katatonie Einfürung in die Phänomenologie, Klinik und Pathophysiologie eines psychomotorischen Syndroms. Stuttgart, Germany: Enke; 1997.
22. Ha AD, Jankovic J. An introduction to dyskinesia-the clinical spectrum. Int Rev Neurobiol. 2011;98:1-29.
23. Fahn S. Hypokinesia and hyperkinesia. In Goetz C, Pappert EJ, Schmitt B, eds. Textbook of Clinical Neurology. New York, NY: Saunders Company; 1999:266-284.
24. Heinrichs DW, Buchanan RW. Significance and meaning of neurological signs in schizophrenia. Am J Psychiatry. 1988;145:11-18.
25. Gottesman II, Gould TD. The endophenotype concept in psychiatry: Etymology and strategic intentions. Am J Psychiatry. 2003;160:636-645.
26. Ungvari GS. Catatonia in DSM 5: Controversies regarding its psychopathology, clinical presentation and treatment response. Neuropsychopharmacol Hung. 2014;16:189-194.
27. Tang VM, Duffin J. Catatonia in the history of psychiatry: Construction and deconstruction of a disease concept. Perspect Biol Med. 2014;57:524-537.
28. Lund CE, Mortimer AM, Rogers D, McKenna PJ. Motor, volitional and behavioural disorders in schizophrenia. 1: Assessment using the modified rogers scale. Br J Psychiatry. 1991;158:323-327, 333.
29. Bush G, Fink M, Petrides G, Dowling F, Francis A. Catatonia. I. Rating scale and standardized examination. Acta Psychiatr Scand. 1996;93:129-136.
30. Northoff G, Koch A, Wenke J, et al. Catatonia as a psychomotor syndrome: A rating scale and extrapyramidal motor symptoms. Mov Disord. 1999;14:404-416.
31. Bräunig P, Krüger S, Shugar G, Höffler J, Börner I. The catatonia rating scale I-development, reliability, and use. Compr Psychiatry. 2000;41:147-158.
32. Carroll BT, Kirkhart R, Ahuja N, et al. Katatonia: A new conceptual understanding of catatonia and a new rating scale. Psychiatry (Edgmont). 2008;5:42-50.
33. Benarous X, Consoli A, Raffin M, et al. Validation of the pediatric catatonia rating scale (PCRS). Schizophr Res. 2016;176:378-386.
34. Rosebush PI, Hildebrand AM, Furlong BG, Mazurek MF. Catatonic syndrome in a general psychiatric inpatient population: Frequency, clinical presentation, and response to lorazepam. J Clin Psychiatry. 1990;51:357-362.
35. Wijemanne S, Jankovic J. Movement disorders in catatonia. J Neurol Neurosurg Psychiatry. 2015;86:825-832.
36. Chen EY, Shapleske J, Luque R, et al. The Cambridge Neurological Inventory: A clinical instrument for assessment of soft neurological signs in psychiatric patients. Psychiatry Res. 1995;56:183-204.
37. Schröder J, Niethammer R, Geider FJ, et al. Neurological soft signs in schizophrenia. Schizophr Res. 1991;6:25-30.
38. Merriam AE, Kay SR, Opler LA, Kushner SF, van Praag HM. Neurological signs and the positive-negative dimension in schizophrenia. Biol Psychiatry. 1990;28:181-192.
39. Krebs MO, Gut-Fayand A, Bourdel M, Dischamp J, Olié J. Validation and factorial structure of a standardized neurological examination assessing neurological soft signs in schizophrenia. Schizophr Res. 2000;45:245-260.
40. Rossi A, De Cataldo S, Di Michele V, et al. Neurological soft signs in schizophrenia. Br J Psychiatry. 1990;157:735-739.
41. Rogers D. Motor disorder in psychiatry. Towards a neurological psychiatry. Chichester, UK: John Wiley & Sons; 1992.
42. Kahlbaum K. Catatonia. Translated by Levij Y and Pridon T (1973). Baltimore, MD: Johns Hopkins University Press; 1874.
43. Kraepelin E. Dementia praecox and Paraphrenia. Translated by RM Barklay (1971). Edinburgh, UK: E. & S. Livingstone; 1919.
44. Bleuler E. Dementia Praecox or the Group of Schizophrenias. Translated by Zinkin J (1950). New York, NY: International University Press; 1908.
45. Wing L, Shah A. A systematic examination of catatonialike clinical pictures in autism spectrum disorders. Int Rev Neurobiol. 2006;72:21-39.
46. Wilson JE, Niu K, Nicolson SE, Levine SZ, Heckers S. The diagnostic criteria and structure of catatonia. Schizophr Res. 2015;164:256-262.
47. Peralta V, Cuesta MJ. Motor features in psychotic disorders. II. Development of diagnostic criteria for catatonia. Schizophr Res. 2001;47:117-126.
48. Pfuhlmann B, Stöber G. The importance of a differentiated psychopathology of catatonia. Acta Psychiatr Scand. 1997;95:357-359.
49. Ungvary GS, Chow LY, Leung HCM, Lau BST. Rating catatonia: Discrepancy between cross-sectional and longitudinal assessment. Rev Psiq Clín. 1999;26:56-61.
50. Steck H. The syndrome extrapyramidal et diencephalique au cours des traitments au largactil et ou serpasil. Ann Med Psychol. 1954;112:737-743.
51. Owens CO. A Guide to the Extrapyramidal Side-Effects of Antipsychotic Drugs. Cambridge, UK: Cambridge University Press; 1999.
52. Ismail B, Cantor-Graae E, McNeil TF. Neurodevelopmental origins of tardivelike dyskinesia in schizophrenia patients and their siblings. Schizophr Bull. 2001;27:629-641.
53. Peralta V, Cuesta MJ. Neuromotor abnormalities in neuroleptic-naive psychotic patients: Antecedents, clinical correlates, and prediction of treatment response. Compr Psychiatry. 2011;52:139-145.
54. Tenback DE, van Harten PN, van Os J. Non-therapeutic risk factors for onset of tardive dyskinesia in schizophrenia: A meta-analysis. Mov Disord. 2009;24:2309-2315.
55. Fenton WS, Blyler CR, Wyatt RJ, McGlashan TH. Prevalence of spontaneous dyskinesia in schizophrenic and non-schizophrenic psychiatric patients. Br J Psychiatry. 1997;171:265-268.
56. Pappa S, Dazzan P. Spontaneous movement disorders in antipsychotic-naïve patients with schizophrenia: A systematic review. Psychol Med. 2009;39:1065-1076.
57. Whitty PF, Owoeye O, Waddington JL. Neurological signs and involuntary movements in schizophrenia: Intrinsic to and informative on systems pathobiology. Schizophr Bull. 2009;35:415-424.
58. Peralta V, Cuesta MJ. The effect of antipsychotic medication on neuromotor abnormalities in neuroleptic-naive nonaffective psychotic patients: A naturalistic study with haloperidol, risperidone, or olanzapine. Prim Care Companion J Clin Psychiatry. 2010;12(2).
59. Cuesta MJ, Campos MS, García-Jalón E, Sánchez-Torres AM, Peralta V. Treatment response of neurological soft signs in drug-naïve patients with a first psychotic episode. Schizophr Res. 2012;139:144-150.
60. Rogers D. Neuropsychiatry of movement disorders. Curr Op Psychiatry. 1992;5:84-87.
61. Chakos MH, Alvir JM, Woerner MG, et al. Incidence and correlates of tardive dyskinesia in first episode of schizophrenia. Arch Gen Psychiatry. 1996;53:313-319.
62. Bonner CA, Kent GH. Overlapping symptoms in catatonic excitement and manic excitement. Am J Psychiatry. 1936;92:1311-1322.
63. Abrams R, Taylor MA, Coleman Stolurow KA. Catatonia and mania: Patterns of cerebral dysfunction. Biol Psychiatry. 1979;14:111-117.
64. Ungvari GS, Leung HC, Lee TS. Benzodiazepines and the psychopathology of catatonia. Pharmacopsychiatry. 1994;27:242-245.
65. Oulis P, Lykouras L, Tomaras V, Panayotopoulou V, Gournellis R, Stefanis C. DSM-IV catatonic features among psychiatric inpatients: A preliminary study. Eur Psychiatry. 1997;12:412-414.
66. Bolton D, Gibb W, Lees A, et al. Neurological soft signs in obsessive compulsive disorder: Standardised assessment and comparison with schizophrenia. Behav Neurol. 1998;11:197-204.
67. Krishna KR, Maniar RC, Harbishettar VS. A comparative study of "Idiopathic catatonia" with catatonia in schizophrenia. Asian J Psychiatr. 2011;4:129-133.
68. Krüger S, Cooke RG, Spegg CC, Bräunig P. Relevance of the catatonic syndrome to the mixed manic episode. J Affect Disord. 2003;74:279-285.
69. Boks MP, Liddle PF, Burgerhof JG, Knegtering R, van den Bosch RJ. Neurological soft signs discriminating mood disorders from first episode schizophrenia. Acta Psychiatr Scand. 2004;110:29-35.
70. Peralta V, Campos MS, de Jalon EG, Cuesta MJ. DSM-IV catatonia signs and criteria in first-episode, drug-naive, psychotic patients: Psychometric validity and response to antipsychotic medication. Schizophr Res. 2010;118:168-175.
71. Usman DM, Olubunmi OA, Taiwo O, Taiwo A, Rahman L, Oladipo A. Comparison of catatonia presentation in patients with schizophrenia and mood disorders in lagos, Nigeria. Iran J Psychiatry. 2011;6:7-11.
72. Grover S, Chakrabarti S, Ghormode D, Agarwal M, Sharma A, Avasthi A. Catatonia in inpatients with psychiatric disorders: A comparison of schizophrenia and mood disorders. Psychiatry Res. 2015;229:919-925.
73. Manschreck TC, Maher BA, Rucklos ME, Vereen DR. Disturbed voluntary motor activity in schizophrenic disorder. Psychol Med. 1982;12:73-84.
74. Dazzan P, Lloyd T, Morgan KD, et al. Neurological abnormalities and cognitive ability in first-episode psychosis. Br J Psychiatry. 2008;193:197-202.
75. Sweet RA, Akil M, Mulsant BH, Ulrich R, Pasternak RE, Zubenko GS. Determinants of spontaneous extrapyramidal symptoms in elderly psychiatric inpatients diagnosed with Alzheimer's disease, major depressive disorder, or psychotic disorders. J Neuropsychiatry Clin Neurosci. 1998;10:68-77.
76. Jaafari N, Baup N, Bourdel MC, et al. Neurological soft signs in OCD patients with early age at onset, versus patients with schizophrenia and healthy subjects. J Neuropsychiatry Clin Neurosci. 2011;23:409-416.
77. Owoeye O, Kingston T, Scully PJ, et al. Epidemiological and clinical characterization following a first psychotic episode in major depressive disorder: Comparisons with schizophrenia and bipolar I disorder in the Cavan-Monaghan First Episode Psychosis Study (CAMFEPS). Schizophr Bull. 2013;39:756-765.
78. Manschreck TC, Ames D. Neurologic features and psychopathology in schizophrenic disorders. Biol Psychiatry. 1984;19:703-719.
79. Cox SM, Ludwig AM. Neurological soft signs and psychopathology: Incidence in diagnostic groups. Can J Psychiatry. 1979;24:668-673.
80. Keshavan MS, Sanders RD, Sweeney JA, et al. Diagnostic specificity and neuroanatomical validity of neurological abnormalities in first-episode psychoses. Am J Psychiatry. 2003;160:1298-1304.
81. Whitty P, Clarke M, McTigue O, et al. Diagnostic specificity and predictors of neurological soft signs in schizophrenia, bipolar disorder and other psychoses over the first 4 years of illness. Schizophr Res. 2006;86:110-117.
82. Mayoral M, Merchán-Naranjo J, Rapado M, et al. Neurological soft signs in juvenile patients with Asperger syndrome, early-onset psychosis, and healthy controls. Early Interv Psychiatry. 2010;4:283-290.
83. Hirjak D, Wolf RC, Koch SC, et al. Neurological abnormalities in recent-onset schizophrenia and asperger-syndrome. Front Psychiatry. 2014;5:91.
84. Tripathi R, Soni A, Tyagi A, Mehta S, Gupta S. Comparative study of neurological soft signs in patients with schizophrenia or obsessive-compulsive disorder, and healthy controls. East Asian Arch Psychiatry. 2015;25:64-72.
85. Chrobak AA, Siwek GP, Siuda-Krzywicka K, et al. Neurological and cerebellar soft signs do not discriminate schizophrenia from bipolar disorder patients. Prog Neuropsychopharmacol Biol Psychiatry. 2016;64:96-101.
86. Bostroem A. Katatone Störungen. In: O. Bumke, ed. Handbuch der Geisteskankheiren. Vol. II. Berlin, Germany: Springer; 1928:134-205.
87. Bleuler E. Zur Theorie des schizophrenen Negativismus. Psychiatrisch-Neurologische Wochenschrift. 1910-1911; 171-176, 184-187, 189-191, 195-198.
88. Giraud P. Conception neurologique du syndrome catatonique. Encephale. 1924;19:571-579.
89. Kleist K. Gegenhalten (motorisher Negativismus), Zwangsgreifen und Thalamus Opticus. Monatschr Psychiat Neurol. 1927;65:317-396.
90. Spoerri T. Motorische Schablonen und Stereotypien bei schizophrenen Endzustanden. Psychiat Neurol Basel. 1967;153:81-127.
91. Pauleikhoff B. Die Katatonie (1868-1968). Fortschr Neurol Psychiat. 1969;37:461-496.
92. Ungvari GS. The Wernicke-Kleist-Leonhard school of psychiatry. Biol Psychiatry. 1993;34:749-752.
93. Fontenelle LF, Mendlowicz MV. The Wernicke-Kleist-Leonhard "short-circuiting": A missing link between attention deficit hyperactivity disorder, Tourette syndrome, and obsessive-compulsive disorder? Med Hypotheses. 2008;71:418-425.
94. Solé-Sagarra J, Leonhard K. Manual de Psiquiatría. Madrid, Spain: Ediciones Morata; 1953.
95. Fish F, Astrup C. The classification of chronic schizophrenia. A follow-up study. Folia Psychiatr Neurol Jpn. 1964;18:17-23.
96. Gjessing LR. A review of periodic catatonia. Biol Psychiatry. 1974;8:23-45.
97. Franzek E, Beckmann H. Different genetic background of schizophrenia spectrum psychoses: A twin study. Am J Psychiatry. 1998;155:76-83.
98. Meyer J, Huberth A, Ortega G, et al. A missense mutation in a novel gene encoding a putative cation channel is associated with catatonic schizophrenia in a large pedigree. Mol Psychiatry. 2001;6:302-306.
99. Stöber G, Saar K, Rüschendorf F, et al. Splitting schizophrenia: Periodic catatonia-susceptibility locus on chromosome 15q15. Am J Hum Genet. 2000;67:1201-1207.
100. Beckmann H, Neumarker KJ. Endogenous psychoses. Leonhard's impact on modern psychiatry. Berlin, Germany: Ullstein Mosby; 1995.
101. Peralta V, Goldberg X, Ribeiro M, Sanchez-Torres AM, Fañanás L, Cuesta MJ. Familiality of psychotic disorders: A polynosologic study in multiplex families. Schizophr Bull. 2016;42:975-983.
102. Guy W. Manual for the classification of endogenous psychoses. 1979. International Network for the History of Neuropsychopharmacology. 2014. http://inhn.org/archives/ guy-collection/manual-for-the-leonhard-classification-ofendogenous-psychoses.html.
103. Pethö B, Ban TA. DCR Budapest-Nashville in the diagnosis and classification of functional psychoses. Psychopathology. 1988;21:149-240.
104. Fritze J, Lanzik M. Schedule for operationalized diagnosis according to the Leonhard classification of endogenous psychoses. Psychopathology. 1990;23:303-315.
105. Peralta V, Cuesta MJ. How many and which are the psychopathological dimensions in schizophrenia? Issues influencing their ascertainment. Schizophr Res. 2001;49:269-285.
106. McKenna PJ, Lund CE, Mortimer AM, Biggins CA. Motor, volitional and behavioural disorders in schizophrenia 2: The 'conflict of paradigms' hypothesis. Br J Psychiatry. 1991;158:328-336.
107. Parker G, Hadzi-Pavlovic D, Brodaty H, et al. Psychomotor disturbance in depression: Defining the constructs. J Affect Dis. 1993;27:255-265.
108. Starkstein SE, Petracca G, Tessón A, et al. Catatonia in depression: Prevalence, clinical correlates, and validation of a scale. J Neurol Neurosurg Psychiat. 1996;60:326-332.
109. Hoeffler J, Braeunig P, Boerner I, Krueger S. Factor-Analysis of Catatonic Schizophrenia. Proceedings and summary. American Psychiatric Association annual meeting. May 30-June 4, 1998: 204-205.
110. Peralta V, Cuesta MJ. Motor features in psychotic disorders. I. Factor structure and clinical correlates. Schizophr Res. 2001a;47:107-116.
111. Krüger S, Bagby RM, Höffler J, Bräunig P. Factor analysis of the catatonia rating scale and catatonic symptom distribution across four diagnostic groups. Compr Psychiatry. 2003;44:472-482.
112. Ungvari GS, Goggins W, Leung S-K, Gerevich J. Schizophrenia with prominent catatonic features ('catatonic schizophrenia') II. Factor analysis of the catatonic syndrome. Prog Neuropsychopharm Biol Psychiatry. 2007;31:462-468.
113. Peralta V, Campos MS, de Jalon EG, Cuesta MJ. DSM-IV catatonia signs and criteria in first-episode, drug-naive, psychotic patients: Psychometric validity and response to antipsychotic medication. Schizophr Res. 2010;118:168-175.
114. Stuivenga M, Morrens M. Prevalence of the catatonic syndrome in an acute inpatient sample. Front Psychiatry. 2014;5:174.
115. Wilson JE, Niu K, Nicolson SE, Levine SZ, Heckers S. The diagnostic criteria and structure of catatonia. Schizophr Res. 2015;164:256-262.
116. Peralta V, de Jalón EG, Campos MS, Basterra V, Sanchez-Torres A, Cuesta MJ. Risk factors, pre-morbid functioning and episode correlates of neurological soft signs in drug-naive patients with schizophrenia-spectrum disorders. Psychol Med. 2011;41:1279-1289.
117. Ojagbemi A, Akpa O, Esan O, Emsley R, Gureje O. The confirmatory factor structure of neurological soft signs in Nigerians with first episode schizophrenia. Neurosci Lett. 2015;589:110-114.
118. Dazzan P, Murray RM. Neurological soft signs in first episode psychosis: A systematic review. Br J Psychiatry. 2002;43:50-57.
119. Dazzan P, Morgan KD, Orr KG, et al. The structural brain correlates of neurological soft signs in AESOP first-episode psychoses study. Brain. 2004;127:143-153.
120. Bombin I, Arango C, Buchanan RW. Significance and meaning of neurological signs in schizophrenia: Two decades later. Schizophr Bull. 2005;31:962-977.
121. Chan RC, Xu T, Heinrichs RW, Yu Y, Wang Y. Neurological soft signs in schizophrenia: A meta-analysis. Schizophr Bull. 2010;36:1089-1104.
122. Ungvari GS, Leung S-K, Shing F, Cheung H-K, Leung T. Schizophrenia with prominent catatonic features ('catatonic schizophrenia') I. Demographic and clinical correlates in the chronic phase. Prog Neuropsychopharm Biol Psychiatry. 2005;29:27-38.
123. Docx L, Morrens M, Bervoets C, et al. Parsing the components of the psychomotor syndrome in schizophrenia. Acta Psychiatr Scand. 2012;126:256-265.
124. Chen EY, Kwok CL, Au JW, Chen RY, Lau BS. Progressive deterioration of soft neurological signs in chronic schizophrenic patients. Acta Psychiatr Scand. 2000;102:342-349.
125. Walker EF, Savoie T, Davis D. Neuromotor precursors of schizophrenia. Schizophr Bull. 1994;20:441-451.
126. Walker E, Lewis N, Loewy R, Palyo S. Motor dysfunction and risk for schizophrenia. Dev Psychopathol. 1999;11:509-523.
127. Bearden CE, Rosso IM, Hollister JM, Sanchez LE, Hadley T, Cannon TD. A prospective cohort study of childhood behavioral deviance and language abnormalities as predictors of adult schizophrenia. Schizophr Bull. 2000;26:395-410.
128. Schiffman J, Walker E, Ekstrom M, Schulsinger F, Sorensen H, Mednick S. Childhood videotaped social and neuromotor precursors of schizophrenia: A prospective investigation. Am J Psychiatry. 2004;161:2021-2027.
129. Rapoport JL, Giedd JN, Gogtay N. Neurodevelopmental model of schizophrenia: Update 2012. Mol Psychiatry. 2012;17:1228-1238.
130. Dazzan P, Griffiths TD. Neurological abnormalities in patients with schizophrenia from singly- and multiply-affected families and their relatives. Chapter Six. In: McDonald, ed. The Maudsley Family Study of Psychosis: A Quest for Intermediate Phenotypes (Maudsley Series). Hove and New York: Psychology Press, Taylor and Francis; 2008:133-154.
131. Hameed MA, Lewis AJ. Offspring of parents with schizophrenia: A systematic review of developmental features across childhood. Harv Rev Psychiatry. 2016;24:104-117.
132. Cioni G, Sgandurra G. Normal psychomotor development. Handb Clin Neurol. 2013;111:3-15.
133. Diamond A. Close interrelation of motor development and cognitive development and of the cerebellum and prefrontal cortex. Child Dev. 2000;71:44-56.
134. Marín O. Developmental timing and critical windows for the treatment of psychiatric disorders. Nat Med. 2016;22:1229-1238.
135. Shaffer D, Schonfeld I, O'Connor PA, et al. Neurological soft signs. Their relationship to psychiatric disorder and intelligence in childhood and adolescence. Arch Gen Psychiatry. 1985;42:342-351.
136. Martins I, Lauterbach M, Slade P, et al. A longitudinal study of neurological soft signs from late childhood into early adulthood. Develop Med Child Neurol. 2008;50:602-607.
137. Fellick JM, Thomson AP, Sills J, Hart CA. Neurological soft signs in mainstream pupils. Arch Dis Child. 2001;85:371-374.
138. Fish B. Neurobiologic antecedents of schizophrenia in children. Evidence for an inherited, congenital neurointegrative defect. Arch Gen Psychiatry. 1977;34:1297-1313.
139. Fish B, Marcus J, Hans SL, Auerbach JG, Perdue S. Infants at risk for schizophrenia: Sequelae of a genetic neurointegrative defect. A review and replication analysis of pandysmaturation in the Jerusalem Infant Development Study. Arch Gen Psychiatry. 1992;49:221-235.
140. McNeil TF, Harty B, Blennow G, Cantor-Graae E. Neuromotor deviation in offspring of psychotic mothers: A selective developmental deficiency in two groups of children at heightened psychiatric risk? J Psychiatr Res. 1993;27:39-54.
141. Mittal VA, Dean DJ, Bernard JA, et al. Neurological soft signs predict abnormal cerebellar-thalamic tract development and negative symptoms in adolescents at high risk for psychosis: A longitudinal perspective. Schizophr Bull. 2014;40:1204-1215.
142. Burton BK, Thorup AA, Jepsen JR, et al. Impairments of motor function among children with a familial risk of schizophrenia or bipolar disorder at 7 years old in Denmark: An observational cohort study. Lancet Psychiatry. 2017;4:400-408.
143. Murray GK, Jones PB, Kuh D, Richards M. Infant developmental milestones and subsequent cognitive function. Ann Neurol. 2007;62:128-136.
144. Jones P, Rodgers B, Murray R, Marmot M. Child development risk factors for adult schizophrenia in the British 1946 birth cohort. Lancet. 1994;344:1398-1402.
145. Mittal VA, Walker EF. Movement abnormalities predict conversion to Axis I psychosis among prodromal adolescents. J Abnorm Psychol. 2007;116:796-803.
146. Callaway DA, Perkins DO, Woods SW, Liu L, Addington J. Movement abnormalities predict transitioning to psychosis in individuals at clinical high risk for psychosis. Schizophr Res. 2014;159:263-266.
147. Dickson H, Laurens KR, Cullen AE, Hodgins S. Metaanalyses of cognitive and motor function in youth aged 16 years and younger who subsequently develop schizophrenia. Psychol Med. 2012;42:743-755.
148. Filatova S, Koivumaa-Honkanen H, Hirvonen N, et al. Early motor developmental milestones and schizophrenia: A systematic review and meta-analysis. Schizophr Res. 2017. doi:10.1016/j.schres.2017.01.029.
149. Walker E, Lewis N, Loewy R, Palyo S. Motor dysfunction and risk for schizophrenia. Dev Psychopathol. 1999;11:509-523.
150. Barkus E, Stirling J, Hopkins R, Lewis S. The presence of neurological soft signs along the psychosis proneness continuum. Schizophr Bull. 2006;32:573-577.
151. Barrantes-Vidal N, Fañanás L, Rosa A, Caparrós B, Dolors Riba M, Obiols JE. Neurocognitive, behavioural and neurodevelopmental correlates of schizotypy clusters in adolescents from the general population. Schizophr Res. 2003;61:293-302.
152. Chan RC, Xu T, Heinrichs RW, Yu Y, Gong QY. Neurological soft signs in non psychotic first-degree relatives of patients with schizophrenia: A systematic review and meta-analysis. Neurosci Biobehav Rev. 2009;34:889-896.
153. Koning JPF, Diederik E, Tenback DE. Dyskinesia and parkinsonism in antipsychotic-naive patients with schizophrenia, first-degree relatives and healthy controls: A meta-analysis. Schizophr Bull. 2010;36:723-731.
154. Koning JP, Kahn RS, Tenback DE, van Schelven LJ, van Harten PN. Movement disorders in nonpsychotic siblings of patients with nonaffective psychosis. Psychiatry Res. 2011;30:133-137.
155. Chan RC, Xie W, Geng FL, et al. Clinical utility and lifespan profiling of neurological soft signs in schizophrenia spectrum disorders. Schizophr Bull. 2016;42:560-570.
156. Braff DL, Ryan J, Rissling AJ, Carpenter WT. Lack of use in the literature from the last 20 years supports dropping traditional schizophrenia subtypes from DSM-5 and ICD-11. Schizophr Bull. 2013;39:751-753.
157. Stompe T, Ortwein-Swodoba G, Ritter K, Marquart B, Schanda RH. The impact of diagnostic criteria on the prevalence of schizophrenia subtypes. Comp Psychiatry. 2005;46:433-439.
158. Kendler KS. Phenomenology of schizophrenia and the representativeness of modern diagnostic criteria. JAMA Psychiatry. 2016;73:1082-1092.
159. Winokur W, Tsuang MT. The Natural History of Mania, Depression and Schizophrenia. Washington, DC: American Psychiatric Press; 1996.
160. Jönsson SAT, Jonsson H. Outcome in untreated schizophrenia: A search for symptoms and traits with prognostic meaning in patients admitted to a mental hospital in the preneuroleptic era. Acta Psychiatr Scand. 1992;85:313-320.
161. Bland RC. Predicting the outcome in schizophrenia. Can J Psychiatry. 1982;27:52-62.
162. World Health Organization. Schizophrenia: An International Follow-up Study. New York, NY: John Wiley and Sons Inc; 1979.
163. van Os J, Fahy TA, Jones P, et al. Psychopathological syndromes in the functional psychoses: Associations with course and outcome. Psychol Med. 1996;26:161-176.
164. McGlashan TH. The prediction of outcome in chronic schizophrenia. IV. The Chestnut follow-up study. Arch Gen Psychiatry. 1986;43:167-176.
165. Pfhol B, Winokur G. The evolution of symptoms in institutionalized hebephrenic/catatonic schizophrenics. Br J Psychiatry. 1982;141:567-572.
166. Nelson HE, Pantelis C, Carruthers K, Speller J, Baxendale S, Barnes TR. Cognitive functioning and symptomatology in chronic schizophrenia. Psychol Med. 1990;20:357-365.
167. Kay SR, Kanofsky D, Lindenmayer JP, Opler LA. The changing presentation of catatonia. Am J Psychiatry. 1987;144:834-835.
168. Peralta V, Moreno-Izco L, Sanchez-Torres A, García de Jalón E, Campos MS, Cuesta MJ. Characterization of the deficit syndrome in drug-naive schizophrenia patients: The role of spontaneous movement disorders and neurological soft signs. Schizophr Bull. 2014;40:214-224.
169. Sachdev P, Hume F, Toohey P, Doutney C. Negative symptoms, cognitive dysfunction, tardive akathisia and tardive dyskinesia. Acta Psychiatr Scand. 1996;93:451-459.
170. Owens DGC, Johnstone EC, Frith CD. Spontaneous involuntary disorders of movement. Their prevalence, severity, and distribution in chronic schizophrenics with and without treatment with neuroleptics. Arch Gen Psychiatry. 1982;39:452-461.
171. Johnstone EC, Owens DGC, Frith CD, Leary J. Disabilities and circumstances of schizophrenic patients. A follow-up study. III. Clinical findings. Abnormalities of the mental state and movement disorder and their correlates. Br J Psychiatry. 1991;suppl 13:21-25.
172. Yarden PE, Discipio WJ. Abnormal movements and prognosis in schizophrenia. Am J Psychiatry. 1971;128:97-103.
173. Manschreck TC, Keuthen NJ, Schneyer ML, Celada MT, Laugheri J, Collins P. Abnormal involuntary movements and chronic schizophrenic disorders. Biol Psychiatry. 1990;27:150-158.
174. Bachmann S, Bottmer C, Schroder J. Neurological soft signs in first-episode schizophrenia: A follow-up study. Am J Psychiatry. 2005;162:2337-2243.
175. Prikryl R, Ceskova E, Kasparek T, Kucerova H. Neurological soft signs, clinical symptoms and treatment reactivity in patients suffering from first episode schizophrenia. J Psychiatr Res. 2006;40:141-146.
176. Cuesta MJ, Campos MS, García-Jalón E, Sánchez-Torres AM, Peralta V. Treatment response of neurological soft signs in drug-naïve patients with a first psychotic episode. Schizophr Res. 2012;139:144-150.
177. Bachmann S, Degen C, Geider FJ, Schröder J. Neurological soft signs in the clinical course of schizophrenia: Results of a meta-analysis. Front Psychiatry. 2014;5:185.
178. Schröder J, Silvestri S, Bubeck B, et al. D2 dopamine receptor up-regulation, treatment response, neurological soft signs, and extrapyramidal side effects in schizophrenia: A follow-up study with 123I-iodobenzamide single photon emission computed tomography in the drug-naive state and after neuroleptic treatment. Biol Psychiatry. 1998;43:660-665.
179. Chan RC, Wang Y, Wang L, et al. Neurological soft signs and their relationships to neurocognitive functions: A re-visit with the structural equation modeling design. PLoS One. 2009;4:e8469.
180. Cuesta MJ, Peralta V, Zarzuela A, Calvo R, García M, Serrano F. Neurological soft-signs in psychosis: Threshold criteria for discriminating normal controls and for predicting cognitive impairment. Schizophr Res. 2002;58:263-271.
181. Peralta V, Cuesta MJ, Serrano JF, Mata I. The Kahlbaum syndrome: A study of its clinical validity, nosological status, and relationship with schizophrenia and mood-disorder. Comp Psychiatry. 1997;38:61-67.
182. Wernicke C. Grundniss der Psychiatrie in klinischen Vorlesungen. Leipzig, Germany: Thieme; 1990.
183. Kleist K. Die klinische Stellung der Motilitätspsychosen. Allg Z Psychiatr. 1912;69:109-112.
184. Benegal V, Hingorani S, Khanna S. Idiopathic catatonia: Validity of the concept. Psychopathology. 1993;26:41-46.
185. Krishna KR, Maniar RC, Harbishettar VS. A comparative study of "Idiopathic catatonia" with catatonia in schizophrenia. Asian J Psychiatr. 2011;4:129-133.
186. Caroff SN, Hurford I, Bleier HR, Gorton GE, Campbell EC. Recurrent idiopathic catatonia: Implications beyond the diagnostic and statistical manual of mental disorders 5th Edition. Clin Psychopharmacol Neurosci. 2015;13:218-221.
187. Lange J. Katatonishe Erscheinungen im Rahmen manish-depressiver Erkrankungen. Monographien aus dem Gesamtgebiete de Neurologie und Psychiatrie 31. Berlin, Germany: Springer; 1922.
188. Bräuning P, Krüger S, Shugar G. Prevalence and clinical significance of catatonic symptoms in mania. Comp Psychiatry. 1998;39:35-46.
189. Krüger S, Cooke RG, Spegg CC, Bräunig P. Relevance of the catatonic syndrome to the mixed manic episode. J Affect Disord. 2003;74:279-285.
190. Taylor ME, Abrams R. Catatonia. Prevalence and importance and importance in the manic phase of manic-depressive illness. Arch Gen Psychiatry. 1977;34:1223-1225.
191. Krüger S, Bräuning P. Catatonia in affective disorder: new findings and a review of the literature. CNS Spectrums. 2000;5:48-53.
192. Abrams R, Taylor MA. Catatonia. A prospective clinical study. Arch Gen Psychiatry. 1976;33:579-581.
193. Casey DE. Mood-dependent tardive dyskinesia. In: Joseph AB, Young RR, ed. Movement disorders in neurology and neuropsychiatry. 2nd ed. Malden, MA: Blackwell Science; 1999:376-379.
194. de Potter RW, Linkowski P. State-dependent tardive dyskinesia in manic-depressive illness. J Neurol Neurosurg Psychiatry. 1983;46:666-668.
195. Yazici O, Kantemir E, Tastaban Y, et al. Spontaneous improvement of tardive dystonia during mania. Br J Psychiatry. 1991;158:847-850.
196. Nasrallah HA, Tippin J, McCalley-Whitters M. Neurological soft signs in manic patients. A comparison with Schizophrenic and control groups. J Affect Disord. 1983;5:45-50.
197. Negash A, Kebede D, Alem A, et al. Neurological soft signs in bipolar I disorder patients. J Affect Disord. 2004;80:221-230.
198. Baş TÖ, Poyraz CA, Baş A, Poyraz BÇ, Tosun M. The impact of cognitive impairment, neurological soft signs and subdepressive symptoms on functional outcome in bipolar disorder. J Affect Disord. 2015;174:336-341.
199. Goswami U, Sharma A, Udayan A, et al. Neuropsychological dysfunction, soft neurological signs and social disability in euthymic patients with bipolar disorder. Br J Psychiatry. 2006;188:366-373.
200. Mrad A, Wassim Krir M, Ajmi I, Gaha L, Mechri A. Neurological soft signs in euthymic bipolar I patients: A comparative study with healthy siblings and controls. Psychiatry Res. 2016;236:173-178.
201. Starkstein S, Gellar S, Parlier M, et al. High rates of parkinsonism in adults with autism. J Neurodevelop Dis. 2015;7:1-11.
202. Bennabi D, Vandel P, Papaxanthis C, Pozzo T, Haffen E. Psychomotor retardation in depression: A systematic review of diagnostic, pathophysiologic, and therapeutic implications. BioMed Res Int. 2013;2013:158746.
203. Parker G, Melancholia HPD. A Disorder of Movement and Mood. Cambridge, UK: Cambridge University Press; 1996.
204. Kraepelin E. Manic-Depressive Insanity and Paranoia. Translated by RM Barklay (1971). Edinbugh, UK: E. & S. Livingstone; 1921.
205. Iwanami T, Maeshima H, Baba H, et al. Psychomotor agitation in major depressive disorder is a predictive factor of mood-switching. J Affect Disord. 2015;170:185-189.
206. Starkstein SE, Petracca G, Chemerinski E, Merello M. Prevalence and correlates of parkinsonism in patients with depression. Neurology. 2001;57:553-555.
207. Zhao Q, Ma YT, Lui SS, et al. Neurological soft signs discriminate schizophrenia from major depression but not bipolar disorder. Prog Neuropsychopharmacol Biol Psychiatry. 2013;43:72-78.
208. Zor R, Keren H, Hermesh H, Szechtman H, Mort J, Eliam D. Obsessive-compulsive disorder: A disorder of pessimal (non-functional) motor behavior. Acta Psychiat Scand. 2009;120:288-298.
209. Zor R, Fineberg N, Hermesh H, et al. Are between-country differences in motor behavior of obsessive-compulsive disorder patients? CNS Spect. 2010;15:445-455.
210. Krüger S, Bräunig P, Höffler J, Shugar G, Börner I, Langkrär J. Prevalence of obsessive-compulsive disorder in schizophrenia and significance of motor symptoms. J Neuropsychiatry Clin Neurosci. 2000;12:16-24.
211. Poyurowsky M, Zoar J, Glick I, et al. Obsessive-compulsive symptoms in schizophrenia: Implications for future psychiatric classifications. Comp Psychiatry. 2012;53:480-483.
212. Cavanna AE, Robertson MM, Critchley HD. Catatonic signs in Gilles de la Tourette syndrome. Cog Behav Neurol. 2008;21:34-37.
213. Hollander E, Schiffman E, Cohen B, et al. Signs of central nervous system dysfunction in obsessive compulsive disorder. Arch Gen Psychiatry. 1990;47:27-32.
214. Pasquini M, Fabbrini G, Moretti G, et al. Bradykinesia in patients with obsessive-compulsive disorder. Eur Psychiatry. 2010;25:378-381.
215. Franklin ME, Harrison JP, Benavides KL. Obsessivecompulsive and tic-related disorders. Child Adolesc Psychiatr Clin N Am. 2012;21:555-571.
216. Gomes de Alvarenga P, de Mathis MA, Dominguez Alves AC, et al. Clinical features of tic related obsessive-compulsive disorder: Results from a large multicenter study. CNS Spectrums. 2012;17:87-93.
217. Wanderer S, Roessner V, Freeman R, et al. Relationship of obsessive-compulsive disorder to age-related comorbidity in children and adolescents with Tourette syndrome. J Develop & Behav Pediatr. 2012;33:124-133.
218. de Vries FE, Cath DC, Hoogendoorn AW, et al. Ticrelated versus tic-free obsessive-compulsive disorder: Clinical picture and 2-year natural course. J Clin Psychiatry. 2016;77:1240-1247.
219. Rogers D. Psychiatric consequences of basal ganglia disease. Semin Neurol. 1990;10:262-266.
220. Obeso JA, Rodriguez-Oroz MC, Stamelou M, Bhatia KP, Burn DJ. The expanding universe of disorders of the basal ganglia. Lancet. 2014;384:523-531.
221. Ratnasuriya RH, Marks IM, Forshaw DM, Hymas NF. Obsessive slowness revisited. Br J Psychiatry. 1991;159:273-274.
222. Hymas N, Lees A, Bolton D, Epps K, Head D. The neurology of obsessional slowness. Brain. 1991;114:2203-2233.
223. Rachman SJ. Primary obsessional slowness. Behav Res Ther. 1974;12:9-18.
224. Veale D. Classification and treatment of obsessional slowness. Br J Psychiatry. 1993;162:198-203.
225. Peng ZW, Xu T, Miao GD, et al. Neurological soft signs in obsessive-compulsive disorder: The effect of co-morbid psychosis and evidence for familiality. Prog Neuropsychopharmacol Biol Psychiatry. 2012;39:200-205.
226. Jaafari N, Fernández de la Cruz L, Grau M, et al. Neurological soft signs in obsessive-compulsive disorder: Two empirical studies and meta-analysis. Psychol Med. 2013;43:1069-1079.
227. Neumärker KJ. Classification matters for catatonia and autism in children. Int Rev Neurobiol. 2006;72:3-19.
228. Shorter E, Watchel LE. Childhood catatonia, autism and psychosis past and present: Is there an "iron triangle"? Acta Psychiatr Scand. 2013;128:21-33.
229. Leonhard K. Über kindliche Katatonien. Psychiatr Neurol Med Psychol. 1960;12:1-17.
230. Stoppelbein L, Greening L, Kakooza A. The importance of catatonia and stereotypies in autistic spectrum disorders. Int Rev Neurobiol. 2006;72:103-118.
231. Ghaziuddin N, Dhossche D, Marcotte K. Retrospective chart review of catatonia in child and adolescent psychiatric patients. Acta Psychiatr Scand. 2012;125:33-38.
232. Breen J, Hare DJ. The nature and prevalence of catatonic symptoms in young people with autism. J Intellect Disabil Res. 2017;61:580-593.
233. Walon H. Syndromes d'insuffisance psychomotrice et types psycho-moteurs. Ann Med Psychol. 1932;4:240-251.
234. Earl CJC. The primitive catatonic psychosis of idiocy. Br J Med Psychol. 1934;14:111-230.
235. Rollings HR. Personality in mongolism with special reference to the incidence of catatonic psychosis. Am J of Mental Deficiency. 1946;2:219-237.
236. Rogers D, Karki C, Bartlett C, Pocock P. The motor disorders of mental handicap. An overlap with the motor disorders of severe psychiatric illness. Br J Psychiatry. 1991;158:97-102.
237. Starkstein S, Gellar S, Parlier M, Payne L, Piven J. High rates of parkinsonism in adults with autism. J Neurodev Disord. 2015;7:29.
238. Campbell M, Locascio JJ, Chorocco MC, et al. Stereotypies and tardive dyskinesia in: Abnormal movements in autistic children. Psychopharmacol Bull. 1990;26:260-266.
239. Jones V, Prior M. Motor imitation abilities and neurological signs in autistic children. J Autism Dev Disord. 1985;15:37-46.
240. Tani P, Lindberg N, Appelberg B, Nieminen-von Wendt T, von Wendt L, Porkka-Heiskanen T. Clinical neurological abnormalities in young adults with Asperger syndrome. Psychiatry Clin Neurosci. 2006;60:253-255.
241. Paquet A, Olliac B, Bouvard MP, Golse B, Vaivre-Douret L. The semiology of motor disorders in autism spectrum disorders as highlighted from a standardized neuro-psychomotor assessment. Front Psychol. 2016;7:1292.
242. Franssen EH, Kluger A, Torossian CL, Reisberg B. The neurologic syndrome of severe Alzheimer's disease: Relationship to functional decline. Arch Neurol. 1993;50:1029-1039.
243. Funkenstein HH, Albert MS, Cook NR, et al. Extrapyramidal signs and other neurologic findings in clinically diagnosed Alzheimer's disease: A community-based study. Arch Neurol. 1993;50:51-56.
244. Hobbelen JSM, Koopmans RTCM, Verhey FRJ, et al. Diagnosing paratonia in the demented elderly: Reliability and validity of the Paratonia Assessment Instrument (PAI). Int Pchychogeriat. 2008;20:840-852.
245. Spalletta G, Mussico M, Padovani A, et al. Neuropsychiatric symptoms and síndromes in a large cohort of newly diagnosed, untreated patients with Alzheimer Disease. Am J Geriatr Psychiatry. 2010;18:1026-1035.
246. Zhao QF, Tan L, Wang H-F, et al. The prevalence of neuropsychiatric symptoms in Alzheimer disease: Systematic review and meta-analysis. J Affect Disord. 2016;190:264-271.
247. Dupré E. Débilité mentale et débilité motrice asocies. Rev Neurol. 1910;20:54-56.
248. Diederich NJ. Paratonia (gegenhalten). In: Kompoliti K, Mentman LV, eds. The Encyclopedia of Movement Disorders. Oxford UK, San Diego, CA: Elsevier, United Press; 2010:376-379.
249. Souren LE, Franssen EH, Reisberg B. Neuromotor changes in Alzheimer's disease: Implications for patients care. J Geriat Psychiatry Neurol. 1997;10:93-98.
250. Vahia I, Cohen CI, Prehogan A, Memmon Z. Prevalence and impact of paratonia in Alzheimer's disease in a multiracial sample. Am J Geriat Psychiatry. 2007;15:351-353.
251. Portet F, Scarmeas N, Cosentino S, Helzner EP, Stern Y. Extrapyramidal signs before and after diagnosis of incident Alzheimer disease in a prospective population study. Arch Neurol. 2009;66:1120-1126.
252. Mitchell SL. Extrapyramidal features in Alzheimer's disease. Age Ageing. 1999;28:401-409.
253. Tsolaki M, Kokarida K, Iakovidou V, Stilopoulos E, Meimaris J, Kazis A. Extrapyramidal symptoms and signs in Alzheimer's disease: Prevalence and correlation with the first symptom. Am J Alzheimers Dis Other Demen. 2001;16:268-278.
254. Louis ED, Tang MX, Schupf N. Mild parkinsonian signs are associated with increased risk of dementia in a prospective, population-based study of elders. Mov Dis. 2010;30:172-178.
255. Scarmeas N, Albert M, Brandt J, et al. Motor signs predict poor outcomes in Alzheimer disease. Neurology. 2005;64:1696-1703.
256. Tosto G, Monsell SE, Hawes SE, Mayeux R. Pattern of extrapyramidal signs in Alzheimer's disease. J Neurol. 2015;262:2548-2556.
257. Urbanowitsch N, Degen C, Toro P, Schröder J. Neurological soft signs in aging, mild cognitive impairment, and Alzheimer's disease - the impact of cognitive decline and cognitive reserve. Front Psychiatry. 2015;6:12.
258. Seidl U, Thomann PA, Schröder J. Neurological soft signs in nursing home residents with Alzheimer's disease. J Alzheimers Dis. 2009;18:525-532.
259. Cuesta MJ, Peralta V, Gil P, Artamendi M. Psychopathological dimensions in first-episode psychoses. From the trunk to the branches and leaves. Eur Arch Psychiatry Clin Neurosci. 2003;253:73-79.
260. Peralta V, Moreno-Izco L, Calvo-Barrena L, Cuesta MJ. The low- and higher-order factor structure of symptoms in patients with a first episode of psychosis. Schizophr Res. 2013;147:116-124.
261. Schneider K. Über und Bedeuting katatonisher Symptome. Zeitschrift für die Gesamte Neurol und Psychiatr. 1914;22:486-505.
262. Fink M, Taylor MA. The catatonia syndrome: Forgotten but not gone. Arch Gen Psychiatry. 2009;66:1173-1177.
263. Tandon R, Heckers S, Bustillo J, et al. Catatonia in DSM-5. Schizophr Res. 2013;150:26-30.
264. Quinn J, Meagher D, Murphy P, Kinsella A, Mullaney J, Waddington JL. Vulnerability to involuntary movements over a lifetime trajectory of schizophrenia approaches 100%, in association with executive (frontal) dysfunction. Schizophr Res. 2001;49:79-87.
265. Mimica N, Folnegović-Smalc V, Folnegović Z. Catatonic schizophrenia in Croatia. Eur Arch Psychiatry Clin Neurosci. 2001;251(suppl 1):17-20.
266. Stöber G. Genetics. In Caroff S, Mann SC, Francis A, Friccione GL, ed. Catatonia. From Psychopathology to Neurobiology. Washington, DC: American Psychiatric Publishing; 2004:173-188.
267. Stöber G, Saar K, Rüschendorf F, et al. Splitting schizophrenia: Periodic catatonia-susceptibility locus on chromosome 15q15. Am J Hum Genet. 2000;67:1201-1207.
268. Rasmussen SA, Mazurek MF, Rosebush PI. Catatonia: Our current understanding of its diagnosis, treatment and pathophysiology. World J Psychiatry. 2016;6:391-398.
269. Lucchini F, Medda P, Mariani MG, Mauri M, Toni C, Perugi G. Electroconvulsive therapy in catatonic patients: Efficacy and predictors of response. World J Psychiat. 2015;22:182-192.
270. Abrams R, Taylor MA. Catatonia: Prediction of response to somatic treatments. Am J Psychiatry. 1977;134:78-80.
271. Northoff G. What catatonia can tell us about "top-down modulation": A neuropsychiatric hypothesis. Behav Brain Sci. 2002;25:555-577.
272. Hirjak D, Thomann PA, Kubera KM, Wolf ND, Sambataro F, Wolf RC. Motor dysfunction within the schizophreniaspectrum: A dimensional step towards an underappreciated domain. Schizophr Res. 2015;169:217-233.
273. Walther S. Psychomotor symptoms of schizophrenia map on the cerebral motor circuit. Psychiatry Res. 2015;233:293-298.
274. Walther S, Horn H, Razavi N, Koschorke P, Müller TJ, Strik W. Quantitative motor activity differentiates schizophrenia subtypes. Neuropsychobiology. 2009;60:80-86.
275. Torres EB, Isenhower RW, Nguyen J, et al. Toward precision psychiatry: Statistical platform for the personalized characterization of natural behaviors. Front Neurol. 2016;7:8.
276. Walther S, Mittal VA. Why we should take a closer look at gestures. Schizophr Bull. 2016;42:259-261.
277. Cuthbert BN, Insel TR. Toward the future of psychiatric diagnosis: The seven pilars of RDoC. BMC Medicine. 2013;11:126.